211 related articles for article (PubMed ID: 22817404)
1. Basal exit site of clinical ventricular tachycardia is an independent predictor of antitachycardia pacing failure in implantable cardioverter-defibrillators recipients.
Boulé S; Brigadeau F; Marquié C; Salleron J; Klug D; Kouakam C; Guédon-Moreau L; Duhamel A; Acheré C; Wissocque L; Lacroix D; Kacet S
Pacing Clin Electrophysiol; 2012 Oct; 35(10):1209-16. PubMed ID: 22817404
[TBL] [Abstract][Full Text] [Related]
2. Antitachycardia pacing for spontaneous rapid ventricular tachycardia in patients with prophylactic cardioverter-defibrillator therapy.
Grimm W; Plachta E; Maisch B
Pacing Clin Electrophysiol; 2006 Jul; 29(7):759-64. PubMed ID: 16884513
[TBL] [Abstract][Full Text] [Related]
3. The use of signal analyses of ventricular tachycardia electrograms to predict the response of antitachycardia pacing in patients with implantable cardioverter-defibrillators.
Tuan TC; Lo MT; Lin YJ; Hsieh WH; Lin C; Huang NE; Lo LW; Chao TF; Liao JN; Hsieh YC; Wu TJ; Chen SA
J Cardiovasc Electrophysiol; 2014 Apr; 25(4):411-417. PubMed ID: 24320556
[TBL] [Abstract][Full Text] [Related]
4. Effect of elevated heart rate preceding the onset of ventricular tachycardia on antitachycardia pacing effectiveness in patients with implantable cardioverter defibrillators.
Kouakam C; Lauwerier B; Klug D; Jarwe M; Marquié C; Lacroix D; Kacet S
Am J Cardiol; 2003 Jul; 92(1):26-32. PubMed ID: 12842240
[TBL] [Abstract][Full Text] [Related]
5. Programming antitachycardia pacing for primary prevention in patients with implantable cardioverter defibrillators: results from the PROVE trial.
Saeed M; Neason CG; Razavi M; Chandiramani S; Alonso J; Natarajan S; Ip JH; Peress DF; Ramadas S; Massumi A
J Cardiovasc Electrophysiol; 2010 Dec; 21(12):1349-54. PubMed ID: 20561107
[TBL] [Abstract][Full Text] [Related]
6. The relationship between pacing site and induction or termination of sustained monomorphic ventricular tachycardia by antitachycardia pacing.
Yee R; Birgersdotter-Green U; Belk P; Jackson T; Christensen J; Wathen MS
Pacing Clin Electrophysiol; 2010 Jan; 33(1):27-32. PubMed ID: 19930109
[TBL] [Abstract][Full Text] [Related]
7. [Therapeutic exhaustion in patients with an implantable cardioverter-defibrillator. Are there predisposing factors?].
Oliveira M; da Silva N; Antunes E; Sousa L; Bico P; Conceição JM; Roquette J; Antunes AM
Rev Port Cardiol; 1998 Dec; 17(12):1013-20. PubMed ID: 9973863
[TBL] [Abstract][Full Text] [Related]
8. Antitachycardia pacing for very fast ventricular tachycardia and low-energy shock for ventricular arrhythmias in patients with implantable defibrillators.
Sivagangabalan G; Chik W; Zaman S; Stafford W; Hayes J; Denman R; Young G; Sanders P; Kovoor P
Am J Cardiol; 2013 Oct; 112(8):1153-7. PubMed ID: 23891430
[TBL] [Abstract][Full Text] [Related]
9. Local activation time derived from stored EGM is associated with failure of antitachycardia pacing in patients with implantable defibrillator.
Lim HS; Lencioni M; Marshall H
Pacing Clin Electrophysiol; 2010 May; 33(5):549-52. PubMed ID: 20015127
[TBL] [Abstract][Full Text] [Related]
10. A randomized study to compare ramp versus burst antitachycardia pacing therapies to treat fast ventricular tachyarrhythmias in patients with implantable cardioverter defibrillators: the PITAGORA ICD trial.
Gulizia MM; Piraino L; Scherillo M; Puntrello C; Vasco C; Scianaro MC; Mascia F; Pensabene O; Giglia S; Chiarandà G; Vaccaro I; Mangiameli S; Corrao D; Santi E; Grammatico A;
Circ Arrhythm Electrophysiol; 2009 Apr; 2(2):146-53. PubMed ID: 19808459
[TBL] [Abstract][Full Text] [Related]
11. [Antitachycardia pacing in patients with left ventricular dysfunction and hemodynamically unstable arrhythmias].
Oliveira M; Antunes E; da Silva N; Martins S; Conceição JM; Roquette J; Antunes AM
Rev Port Cardiol; 1999 Feb; 18(2):161-6. PubMed ID: 10221046
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the duration of the basal QRS complex and electrical therapies for ventricular tachycardias among ICD patients.
Jiménez-Candil J; Ruiz M; Herrero J; León V; Martín A; Moriñigo J; Ledesma C; Martín-Luengo C
Pacing Clin Electrophysiol; 2010 May; 33(5):596-604. PubMed ID: 20025704
[TBL] [Abstract][Full Text] [Related]
13. BIVentricular versus right ventricular antitachycardia pacing to terminate ventricular tachyarrhythmias in patients receiving cardiac resynchronization therapy: the ADVANCE CRT-D Trial.
Gasparini M; Anselme F; Clementy J; Santini M; Martínez-Ferrer J; De Santo T; Santi E; Schwab JO;
Am Heart J; 2010 Jun; 159(6):1116-1123.e2. PubMed ID: 20569728
[TBL] [Abstract][Full Text] [Related]
14. Right ventricular pacing is an independent predictor for ventricular tachycardia/ventricular fibrillation occurrence and heart failure events in patients with an implantable cardioverter-defibrillator.
Gardiwal A; Yu H; Oswald H; Luesebrink U; Ludwig A; Pichlmaier AM; Drexler H; Klein G
Europace; 2008 Mar; 10(3):358-63. PubMed ID: 18308756
[TBL] [Abstract][Full Text] [Related]
15. Prospective randomized multicenter trial of empirical antitachycardia pacing versus shocks for spontaneous rapid ventricular tachycardia in patients with implantable cardioverter-defibrillators: Pacing Fast Ventricular Tachycardia Reduces Shock Therapies (PainFREE Rx II) trial results.
Wathen MS; DeGroot PJ; Sweeney MO; Stark AJ; Otterness MF; Adkisson WO; Canby RC; Khalighi K; Machado C; Rubenstein DS; Volosin KJ;
Circulation; 2004 Oct; 110(17):2591-6. PubMed ID: 15492306
[TBL] [Abstract][Full Text] [Related]
16. The value of defibrillator electrograms for recognition of clinical ventricular tachycardias and for pace mapping of post-infarction ventricular tachycardia.
Yoshida K; Liu TY; Scott C; Hero A; Yokokawa M; Gupta S; Good E; Morady F; Bogun F
J Am Coll Cardiol; 2010 Sep; 56(12):969-79. PubMed ID: 20828650
[TBL] [Abstract][Full Text] [Related]
17. Incidence and clinical relevance of slow ventricular tachycardia in implantable cardioverter-defibrillator recipients: an international multicenter prospective study.
Sadoul N; Mletzko R; Anselme F; Bowes R; Schöls W; Kouakam C; Casteigneau G; Luise R; Iscolo N; Aliot E;
Circulation; 2005 Aug; 112(7):946-53. PubMed ID: 16103252
[TBL] [Abstract][Full Text] [Related]
18. Strategic programming of detection and therapy parameters in implantable cardioverter-defibrillators reduces shocks in primary prevention patients: results from the PREPARE (Primary Prevention Parameters Evaluation) study.
Wilkoff BL; Williamson BD; Stern RS; Moore SL; Lu F; Lee SW; Birgersdotter-Green UM; Wathen MS; Van Gelder IC; Heubner BM; Brown ML; Holloman KK;
J Am Coll Cardiol; 2008 Aug; 52(7):541-50. PubMed ID: 18687248
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and safety of different antitachycardia pacing sites in the termination of ventricular tachycardia in patients with biventricular implantable cardioverter-defibrillator.
Haghjoo M; Hajahmadi M; Fazelifar AF; Sadr-Ameli MA
Europace; 2011 Apr; 13(4):509-13. PubMed ID: 21296776
[TBL] [Abstract][Full Text] [Related]
20. Ventricular tachycardia in arrhythmogenic right ventricular dysplasia/cardiomyopathy: clinical presentation, risk stratification and results of long-term follow-up.
Pezawas T; Stix G; Kastner J; Schneider B; Wolzt M; Schmidinger H
Int J Cardiol; 2006 Mar; 107(3):360-8. PubMed ID: 16503259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
